Medicine and Dentistry
Development
100%
Nephropathy
100%
Thrombospondin 1
100%
Doxorubicin
100%
Podocyte
63%
Injury
27%
Diabetes Mellitus
18%
Proteinuria
18%
Therapeutic Procedure
9%
In Vitro
9%
Stimulation
9%
Cytoskeleton
9%
Programmed Cell Death
9%
Foot
9%
Inflammation
9%
Glomerulus
9%
Diabetic Nephropathy
9%
Nephritic Syndrome
9%
Adriamycin-Induced Nephropathy
9%
Glomerulosclerosis
9%
Macrophage
9%
Disorientation
9%
Actin
9%
Immunology and Microbiology
Development
100%
Thrombospondin 1
100%
Kidney
100%
Podocyte
63%
Inflammation
9%
Macrophage
9%
Mouse Model
9%
CD36
9%
Cytoskeleton
9%
Foot
9%
Glomerulus
9%
Apoptosis
9%
Actin
9%
Nephritis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Thrombospondin 1
100%
Kidney Disease
100%
Injury
27%
Diabetes Mellitus
18%
Proteinuria
18%
Mouse Model
9%
Apoptosis
9%
Nephritis
9%
Inflammation
9%
Actin
9%
Diabetic Nephropathy
9%
Glomerulosclerosis
9%
Disorientation
9%
Adriamycin-Induced Nephropathy
9%
Biochemistry, Genetics and Molecular Biology
Development
100%
Thrombospondin 1
100%
Doxorubicin
100%
Podocyte
63%
Mouse Model
9%
Macrophage
9%
Cytoskeleton
9%
Apoptosis
9%
CD36
9%
Actin
9%